Inflammatory bowel disease in the elderly

Gastroenterology Clinics of North America

Volumn 30, Issue 2, 2001, Pages 409-426

  Robertson, Douglas J ^a,b   Grimm, Ian S ^c,d  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b Section of Gastroenterology   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

^d UNIVERSITY OF NORTH CAROLINA HOSPITALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; INFLIXIMAB; MERCAPTOPURINE;

AGED; AGING; BONE ATROPHY; CLINICAL FEATURE; CROHN DISEASE; DIFFERENTIAL DIAGNOSIS; DIVERTICULOSIS; ENTERITIS; HUMAN; HYPERTENSION; ISCHEMIC COLITIS; OSTEOPOROSIS; PANCREATITIS; REVIEW; ULCERATIVE COLITIS;

EID: 0034967804     PISSN: 08898553     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8553(05)70188-6     Document Type: Article

References (123)

1. Recommendation for the prevention and treatment of glucocorticoid-induced osteoporosis. American college of rheumatology task force on osteoporosis guidelines
2. From the Centers for Disease Control and Prevention: Escherichia coli O157:H7 infections associated with eating a nationally distributed commercial brand of frozen ground beef patties and burgers - Colorado, 1997
3. Immunosenescence and mucosal immunity: Significant effects of old age on secretory IgA concentrations and intraepithelial lymphocyte counts
4. Lymphocytic colitis: A distinct clinical entity? A clinicopathological confrontation of lymphocytic and collagenous colitis
5. An overview of special considerations in the evaluation and management of the geriatric patient
6. Ileal pouch-anal anastomosis: A single surgeon's experience with 100 consecutive cases
7. Ticlopidine induced colitis: A histopathological study including apoptosis
8. Human Escherichia coli O157:H7 infection associated with the consumption of unpasteurized goat's milk
9. Incidence and prevalence of ulcerative colitis and Crohn's disease in the County of Copenhagen, 1962 to 1978
10. Reduced bone density in patients with inflammatory bowel disease
11. Dysplasia-associated lesion or mass (DALM) detected by colonoscopy in long-standing ulcerative colitis: An indication for colectomy
12. Screening for Escherichia coli O157:H7 - A nationwide survey of clinical laboratories
13. Colitis in the elderly: A reappraisal
14. Clinical characteristics and natural history of colitis in the elderly
15. Inflammatory bowel disease: Specific concerns in the elderly
16. Aetiology of ulcerative colitis: II. A new hypothesis
17. Inflammatory bowel disease in the older patient
18. A severe outbreak of Escherichia coli O157:H7 - Associated hemorrhagic colitis in a nursing home
19. Hamburger-associated Escherichia coli O157:H7 infection in Las Vegas: A hidden epidemic
20. Hormone replacement therapy prevents bone loss in patients with inflammatory bowel disease
21. Longitudinal study of cortical bone loss in patients with inflammatory bowel disease
22. The incidence and prevalence of inflammatory bowel disease in North Tees Health District
23. Ulcerative colitis in the elderly patient
24. Escherichia coli O157:H7
25. Escherichia coli O157:H7 and its significance in foods
26. Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease
27. Secretory immune responses in ageing rats: II. Phenotype distribution of lymphocytes in secretory and lymphoid tissues
28. The epidemiology of inflammatory bowel disease: A large, population-based study in Sweden
29. Survival and causes of death in patients with inflammatory bowel disease: A population-based study
30. Polypectomy may be adequate treatment for adenoma-like dysplastic lesions in chronic ulcerative colitis
31. An epidemiological study of ulcerative colitis and regional enteritis in the Oxford area
32. Crohn's disease in the elderly
33. Clinical features and epidemiological data on Crohn's disease in the Basle area
34. Crohn's disease in the city of Derby, 1951-85
35. Efficacy of open-label bismuth subsalicylate for the treatment of microscopic colitis
36. Epidemiology of Crohn's disease in the Jewish population of central Israel, 1970-1980
37. Crohn's disease in the elderly: Prolonged delay in diagnosis
38. Incidence rates of ulcerative colitis and Crohn's disease in fifteen areas of the United States
39. The atypical colitides
40. Colorectal cancer in patients with ulcerative colitis: A population study in central Israel
41. Crohn's-like reaction in diverticular disease
42. Incidence of inflammatory bowel disease in northern France (1988-1990)
43. Inflammatory bowel disease in the elderly
44. Inflammatory bowel disease
45. Inflammatory bowel disease
46. Crohn's disease in the elderly: A statistical comparison with younger patients matched for sex and duration of disease
47. General perspectives on the aged gut
48. Postmortem survey of diverticular disease of the colon: I. Diverticulosis and diverticulitis
49. Proctocolectomy and ileostomy to pouch surgery for ulcerative colitis
50. Segmental colitis associated with diverticula: A prospective study
51. Does ulcerative colitis behave differently in the elderly?
52. Assessment of colorectal cancer risk in patients with ulcerative colitis: Experience from a private practice
53. Immunoregulatory defects in murine aged Peyer's patches
54. Immune-related alterations in aged gut-associated lymphoid tissues in mice
55. An epidemiological study of Crohn's disease in Northeast Scotland
56. Crohn's disease in the northeastern and northern Isles of Scotland: An epidemiological review
57. Incidence of Crohn's disease in Stockholm County 1955-1989
58. Crohn's disease in Blackpool - Incidence and prevalence 1968-80
59. The incidence of Crohn's disease is not decreasing in Sweden
60. Crohn's disease of the large bowel
61. Crohn's disease in Olmsted County, Minnesota, 1940-1993: Incidence, prevalence, and survival
62. Ulcerative colitis in Olmsted County, Minnesota, 1940-1993: Incidence, prevalence, and survival
63. Pouchitis and extraintestinal manifestations of inflammatory bowel disease after ileal pouch-anal anastomosis
64. Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: A randomised phase III trial
65. Diverticular disease-associated chronic colitis
66. Prevalence of colonic diverticulosis in general population of Oxford area
67. Ticlopidine-induced lymphocytic colitis
68. Incidence and prevalence of ulcerative colitis and Crohn's disease in urban and rural areas of Spain from 1981 to 1988
69. Mortality in Crohn's disease
70. J ileal pouch-anal anastomosis for chronic ulcerative colitis: Complications and long-term outcome in 1310 patients
71. Medical therapy of specific clinical presentations
72. Ulcerative colitis in Finland: I. Cases treated at central hospitals, 1956-1967
73. Incidence of ulcerative colitis and indeterminate colitis in four counties of southeastern Norway, 1990-93: A prospective population-based study
74. Intestinal cancer risk and mortality in patients with Crohn's disease
75. Incidence and prevalence of Crohn's disease in the county of Copenhagen, 1962-87: A sixfold increase in incidence
76. Epidemiology of ulcerative colitis and regional enterocolitis (Crohn's disease) in Norway
77. Abdominal surgery in the older Crohn's population
78. Use of azathioprine or 6-mercaptopurine in the treatment of Crohn's disease
79. The clinical and functional outcome after restorative proctocolectomy: A prospective study in 100 patients
80. General and cancer specific mortality of a population based cohort of patients with inflammatory bowel disease: The Florence Study
81. Drug-responsive chronic segmental colitis associated with diverticula: A clinical syndrome in the elderly
82. Survival and cause-specific mortality in inflammatory bowel disease: A population-based cohort study
83. Crohn's disease: Influence of age at diagnosis on site and clinical type of disease
84. 6-Mercaptopurine in the management of inflammatory bowel disease: Short- and long-term toxicity
85. 6-Mercaptopurine in the management of inflammatory bowel disease: Short- and long-term toxicity
86. Infliximab for the treatment of fistulas in patients with Crohn's disease
87. Age-related clinical severity at diagnosis in 1705 patients with ulcerative colitis: A study by GISC
88. Hemorrhagic colitis associated with a rare Escherichia coli serotype
89. Cardiff Crohn's disease jubilee: The incidence over 50 years
90. Colonoscopic polypectomy in chronic colitis: Conservative management after endoscopic resection of dysplastic polyps
91. Crohn's disease in the older patient
92. Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease
93. Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis
94. Pouchitis following ileal pouch-anal anastomosis: Definition, pathogenesis, and treatment
95. Lymphocytic colitis during ticlopidine therapy
96. A prospective study of first attacks of inflammatory bowel disease and infectious colitis: Clinical findings and early diagnosis
97. Crohn's disease in the elderly
98. Epidemiology of Crohn's disease in Regio Leiden, The Netherlands: A population study from 1979 to 1983
99. Nonspecific proctocolitis in northeastern Scotland: A community study
100. Is segmental colitis a complication of diverticular disease?
101. Escherichia coli O157:H7 diarrhea in the United States: Clinical and epidemiologic features
102. Incidence of ulcerative colitis in Cardiff over 20 years: 1968-87
103. Crohn's disease in the elderly
104. Crohn's disease in the elderly
105. Ulcerative colitis and indetermine colitis in the city of Malmo, Sweden: A 25-year incidence study
106. Colorectal cancer in ulcerative colitis: Influence of anatomical extent and age at onset on colitis-cancer interval
107. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease
108. Infectious colitis endoscopically simulating inflammatory bowel disease: A prospective evaluation
109. Incidence of Crohn's disease in Cardiff over 60 years: 1986-1990 an update
110. A comparison of budesonide and mesalamine for active Crohn's disease
111. A population-based study of inflammatory bowel disease in Florence over 15 years (1978-92)
112. Ulcerative proctocolitis in Orebro, Sweden: A retrospective epidemiologic study, 1963-1987
113. Prevention and treatment of osteoporosis in patients with inflammatory bowel disease
114. Regional enteritis
115. Yersinia enteritis
116. Fracture risk is increased in Crohn's disease, but not in ulcerative colitis
117. Crohn's disease in the elderly: A comparison with young adults
118. General outbreaks of vero cytotoxin producing Escherichia coli O157 in England and Wales from 1992 to 1994
119. Early results of surgery for ulcerative colitis
120. Surgical therapy for ulcerative colitis
121. Early and late onset ulcerative colitis: Distinct clinical features